NCT03315598 is a NA clinical trial of Electroacupuncture in Neuralgia, sponsored by Seoul National University.

Who is sponsoring NCT03315598?

NCT03315598 is sponsored by Seoul National University.

What drugs are being tested in NCT03315598?

Interventions in NCT03315598: Electroacupuncture.

What condition does NCT03315598 study?

NCT03315598 studies Neuralgia, Neuralgia; Postherpetic, Diabetic Neuropathy, Painful, Failed Back Surgery Syndrome.

Is NCT03315598 still recruiting?

NCT03315598 is currently completed. Last updated 14 September 2022.

Last reviewed 2022-09-14 · How we verify

NCT03315598

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain

Completed NA Last updated 14 September 2022

What this trial tests

NA trial testing Electroacupuncture in Neuralgia in 22 participants. Completed in 23 February 2018.

Timeline

15 May 2017

Primary endpoint
23 February 2018

23 February 2018

Quick facts

Lead sponsor	Seoul National University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	15 May 2017
Primary completion	23 February 2018
Estimated completion	23 February 2018
Sites	1 location across South Korea

Drugs / interventions tested

Electroacupuncture

Conditions studied

Neuralgia — all drugs for Neuralgia →
Neuralgia; Postherpetic — all drugs for Neuralgia; Postherpetic →
Diabetic Neuropathy, Painful — all drugs for Diabetic Neuropathy, Painful →
Failed Back Surgery Syndrome — all drugs for Failed Back Surgery Syndrome →

Sponsor

Seoul National University

Who can join

18 and older, any sex, with Neuralgia or Neuralgia; Postherpetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Electroacupuncture May Improve Burning and Electric Shock-Like Neuropathic Pain: A Prospective Exploratory Pilot Study.
Lee S, Lee CS, Moon JY, Song HG, et al · · 2020 · cited 10× · PMID 33074703 · DOI 10.1089/acm.2020.0307

Verify or expand the search:

Other trials of Electroacupuncture

Trials testing the same drug.

NCT07530042 — Efficacy of Electroacupuncture Combined With Auricular Acupressure for Chronic Low Back Pain. · NA · not yet recruiting
NCT07509294 — Effect Of Electroacupuncture With Local Anesthesia On Pain And Stress During Impacted Lower Third Molar Surgery · NA · not yet recruiting
NCT07515027 — Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung · NA · recruiting
NCT07487532 — Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation · NA · not yet recruiting
NCT07489625 — Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain · EARLY_PHASE1 · not yet recruiting

Other recruiting trials for Neuralgia

Currently open trials in the same condition.

NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
NCT06796595 — Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of Pudendal an · recruiting
NCT05817786 — Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots · NA · recruiting

Other Seoul National University trials

Trials by the same sponsor.

NCT07385534 — Effects of Lower Body EMS Training in Postmenopausal Women · NA · recruiting
NCT06751108 — Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients · active not recruiting
NCT06703697 — Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe) · NA · recruiting
NCT06130514 — The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block · NA · not yet recruiting
NCT06470581 — Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03315598 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University
Last refreshed: 14 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03315598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing